Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020
Summary Medical Devices sector report, “Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Therapeutic Drug Monitoring Tests reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat. Test kits for measurement of both proteins based and chemical based therapeutic drugs are covered.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope - Extensive coverage of the Therapeutic Drug Monitoring Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Therapeutic Drug Monitoring Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Therapeutic Drug Monitoring Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Our reports have been used by over 10K customers, including:
314 pages •
By Global Industry Analysts
• Jan 2021
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 16
- Influencer Pool: 1653
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions.It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage.Its major products include cochlear implant...
Summary Compumedics Ltd (Compumedics) is a medical device company.It develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems.It provides product categories such as sleep diagnostics, neurology diagnostics, brain research...
Muscarinic Acetylcholine Receptor M2 - Pipeline Review, H2 2020
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Muscarinic cholinergic receptor 2 is an acetylcholine receptor. It is expressed in various regions of the brain including the cerebellum, cerebral cortex, hippocampus, medulla,...
The research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research...
Sjogren’s Syndrome (SS) - Opportunity Analysis and Forecasts to 2029
Sjögren’s syndrome (SS) is a chronic and systemic autoimmune inflammatory disorder in which an initial immunological attack that primarily targets the lacrimal and salivary glands.Although most characteristically clinical...
Increasing R&D spending and initiatives for rare disease and orphan drugs research are set to drive the drug discovery services market.’’
The drug discovery services market is projected to reach USD 21.4 billion by 2025 from USD 11.1 billion in 2020, at a CAGR of 14.0% during the forecast period. The major factors driving the growth of...
2020 Diarrhea PIPELINE HIGHLIGHTS
Diarrhea is one of the widely researched conditions during 2020 with 29 companies actively focusing on realizing pipeline’s potential. Development of Diarrhea medicines is identified as integral to the strategy of the majority of companies operating in the industry.
Opioid Use Disorder: Opportunity Analysis and Forecasts to 2028
Opioids are synthetic or natural agents that stimulate opioid receptors in the brain and nervous system.Opioids are often used to treat patients suffering from pain.
When taken in the prescribed quantities, opioids...
Use Of Prescription Drugs
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.